HopeStage
Study directory

Depression studies

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

Back to overview
More filters: keywords, city, remote
7264studies shown
Showing 241-252 of 7,264
Other study type icon
Not Yet RecruitingNCT07602153

Multimodal Pharmacological Study of Clinical Cohorts for Major Depressive Disorder

Official study title

Multimodal Pharmacological Study of Clinical Cohorts for Major Depressive Disorder - Sub-task 2: A Longitudinal Imaging-Proteomics Study on Suicidal Tendency and Mechanisms of Rapid Antidepressant Effects

This study isn't recruiting yet.

Location not clearly listed
DepressionObservational studyAges 18–65
Countries
Sponsor
Shanghai Mental Health Center
Drug study icon
Not Yet RecruitingNCT07685964

Pregnenolone for Addiction and Depression

Official study title

Advancing Pregnenolone as a Novel Therapy for Co-Occurring Cannabis Use Disorder and Depression

This study isn't recruiting yet.

Multiple locations, including Dallas
Depression, AddictionMedication studyAges 18–50
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Behavioral study icon
Not Yet RecruitingNCT06705270

Sedation and Guided Education for Depression Study

Official study title

Randomized Controlled Trial Comparing the Impact of Patient Education Strategies on the Antidepressant Response to Propofol Sedation

This study isn't recruiting yet.

Location not clearly listed
DepressionMedication studyAges 18+
Countries
Sponsor
Stanford University
Other study type icon
Not Yet RecruitingNCT07625163

The Effects of Aerobic Exercise and Mindful Breathing on Individuals With Major Depressive Disorder in Saudi Arabia

Official study title

The Effects of Aerobic Exercise and Mindful Breathing on Symptom Severity and Quality of Life in Individuals With Major Depressive Disorder in Saudi Arabia: A Randomised Clinical Trial Protocol

This study isn't recruiting yet.

Multiple locations, including Al Kharj
DepressionInterventional studyAges 18–60
Countries
Saudi Arabia
Sponsor
University of Pretoria
Drug study icon
Enrolling By InvitationNCT07161700

Safety study of SPT-300 (GlyphAllo) in depression

Official study title

A 6-Week, Multicenter, Open-Label, Monotherapy, Extension Study of SPT-300 in Adults With Major Depressive Disorder, With or Without Anxious Distress

This study is by invitation only.

Multiple locations, including Chino
DepressionMedication studyAges 18–66
Countries
United States, Bulgaria, Czechia, + 4 others
Sponsor
Seaport Therapeutics
Other study type icon
Enrolling By InvitationNCT07345858

Salivary Oxytocin as a Biomarker of Psychedelic Treatment

Official study title

Salivary Oxytocin as a Biomarker of Psychedelic Assisted Psychotherapy in Patients With Major Depressive Disorder

This study is by invitation only.

In Geneva
DepressionObservational studyAges 18+
Countries
Switzerland
Sponsor
University of Geneva, Switzerland
Drug study icon
Not recruitingEUCTR 2022-000430-42

An Open-label, Long-term, Safety and Efficacy Study of Aticaprant as Adjunctive Therapy in Adult and Elderly Participants With Major Depressive Disorder (MDD)

This study isn't currently recruiting.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

Multiple locations, including Alken
DepressionHistorical research record
Countries
France, Belgium, Bulgaria, + 8 others
Sponsor
Janssen-Cilag International NV
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.